Financial Ratios CEMATRIX Corporation Toronto S.E.
Equities
CVX
CA15120R1038
Construction & Engineering
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% | -.--% | -.--% |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -1.65 | -3.85 | -6.36 | -7.85 | 3.76 | |||||
Return on Total Capital | -2.16 | -5.02 | -7.49 | -8.88 | 4.48 | |||||
Return On Equity % | -4.12 | -236.96 | -11.5 | -18.75 | 4.37 | |||||
Return on Common Equity | -4.12 | -236.96 | -11.5 | -18.75 | 4.37 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 25.62 | 21.15 | 17.25 | 8.68 | 22.29 | |||||
SG&A Margin | 24.04 | 24.71 | 29.33 | 25.02 | 17.15 | |||||
EBITDA Margin % | 3.81 | 1.09 | -7.86 | -14.06 | 7.52 | |||||
EBITA Margin % | -0.49 | -3.95 | -13.3 | -18.44 | 4.52 | |||||
EBIT Margin % | -2.96 | -6.84 | -16.48 | -18.44 | 4.52 | |||||
Income From Continuing Operations Margin % | -1.12 | -36.8 | -8.21 | -19.17 | 2.32 | |||||
Net Income Margin % | -1.12 | -36.8 | -8.21 | -19.17 | 2.32 | |||||
Net Avail. For Common Margin % | -1.12 | -36.8 | -8.21 | -19.17 | 2.32 | |||||
Normalized Net Income Margin | -3.46 | -22.79 | -6.23 | -13.71 | 1.98 | |||||
Levered Free Cash Flow Margin | 3.16 | 6.23 | -14.26 | -13.54 | -4.2 | |||||
Unlevered Free Cash Flow Margin | 6.14 | 10.64 | -10.88 | -11.07 | -3.48 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.89 | 0.9 | 0.62 | 0.68 | 1.33 | |||||
Fixed Assets Turnover | 2.26 | 1.92 | 1.79 | 2.33 | 4.14 | |||||
Receivables Turnover (Average Receivables) | 4.64 | 6.09 | 5.03 | 4.75 | 5.29 | |||||
Inventory Turnover (Average Inventory) | 32.53 | 30.96 | 26.53 | 30.65 | 40.43 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.81 | 0.51 | 5.67 | 1.92 | 2.15 | |||||
Quick Ratio | 0.68 | 0.43 | 5.34 | 1.77 | 1.97 | |||||
Operating Cash Flow to Current Liabilities | 0.03 | 0.1 | -0.18 | -0.32 | 0.06 | |||||
Days Sales Outstanding (Average Receivables) | 78.64 | 60.1 | 72.54 | 76.88 | 68.96 | |||||
Days Outstanding Inventory (Average Inventory) | 11.22 | 11.82 | 13.76 | 11.91 | 9.03 | |||||
Average Days Payable Outstanding | 32.29 | 24.34 | 33.9 | 45.88 | 38.47 | |||||
Cash Conversion Cycle (Average Days) | 57.57 | 47.58 | 52.39 | 42.91 | 39.52 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 207.56 | 3.16K | 26.58 | 27.31 | 11.29 | |||||
Total Debt / Total Capital | 67.49 | 96.94 | 21 | 21.45 | 10.15 | |||||
LT Debt/Equity | 142.06 | 1.5K | 21.97 | 9.19 | 5.57 | |||||
Long-Term Debt / Total Capital | 46.19 | 45.91 | 17.36 | 7.22 | 5.01 | |||||
Total Liabilities / Total Assets | 74.91 | 97.64 | 28.85 | 32.03 | 26.87 | |||||
EBIT / Interest Expense | -0.62 | -0.97 | -3.04 | -4.67 | 3.93 | |||||
EBITDA / Interest Expense | 1.03 | 0.44 | -1.01 | -3.05 | 7.6 | |||||
(EBITDA - Capex) / Interest Expense | 0.41 | 0.38 | -1.56 | -4.69 | 4.39 | |||||
Total Debt / EBITDA | 14.18 | 25.87 | -6.78 | -2.17 | 0.7 | |||||
Net Debt / EBITDA | 13.37 | 22.89 | 9.33 | 0.89 | -0.05 | |||||
Total Debt / (EBITDA - Capex) | 35.32 | 30.33 | -4.39 | -1.41 | 1.2 | |||||
Net Debt / (EBITDA - Capex) |